Evidence map›Paper›PMID 18023519›Full record

ArticleExperimental hematology2008

Bcl2 enhances induced hematopoietic differentiation of murine embryonic stem cells.

Yan-Yi Wang, Xingming Deng, Lijun Xu, Fengqin Gao, Tammy Flagg, W Stratford May

Open access · bronzeAbstract read
In one paragraph

Article in Experimental hematology, 2008. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
0.5field-weighted citation impact, top 35% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed, 13 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Review
  7. Article
  8. Article
  9. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 2 institutions in 1 country.

Yan-Yi WangUniversity of Florida Shands Cancer Center and Department of Medicine, University of Florida, Gainesville, FL 32610-3633, USA.
Xingming Deng
Lijun Xu
Fengqin Gao
Tammy Flagg
W Stratford May
UF Health Cancer CenterUniversity of Florida Health · US

Funding

IL3 GROWTH FACTOR SIGNALINGR01CA044649 · NCI · UNIVERSITY OF TEXAS MEDICAL BR GALVESTON · PI MAY, WILLIAM STRATFORD · 1987 to 2010
$2.8M
NCI NIH HHS CA 44649NCI NIH HHS R01 CA044649
6 · The paper itself

Abstract

Bcl2 is a potent antiapoptotic gene that can increase resistance of adult bone marrow hematopoietic progenitor cells to lethal irradiation, and thereby preserve their ability to differentiate. However, the effect of Bcl2 on murine embryonic stem (ES) cells induced to undergo hematopoietic differentiation in the absence of a toxic stress is not known. To test this, murine CCE-ES cells that can be induced to undergo hematopoietic differentiation in a two-step process that results in upregulation of Bcl2 were used. Upregulation of Bcl2 precedes formation of hematopoietic embryoid bodies (EB) and their further differentiation into hematopoietic colony-forming units, when plated as single cells in methylcellulose. ES cells stably expressing a Bcl2 siRNA plasmid to "knock-down" endogenous expression or cells expressing wild-type (WT) Bcl2 or phosphomimetic Bcl2 mutants were examined. ES cells expressing the Bcl2 siRNA or those expressing a dominant-negative, nonphosphorylatable Bcl2 display a strikingly reduced capacity to form hematopoietic EBs and colony-forming units compared to cells expressing WT or phosphomimetic Bcl2 that demonstrate an increased capacity. Bcl2's effect on induced-hematopoietic differentiation of ES cells does not result from either decreased apoptosis or a reduced number of cells. Rather, Bcl2-enhances hematopoietic differentiation of ES cells by upregulating p27, which results in retardation of the cell cycle at G1/G 0. Thus siRNA silencing of p27 reverts Bcl2's enhancement phenotype in a manner similar to that of Bcl2 "silencing" or expression of a nonphosphorylable Bcl2. In addition to Bcl2's well-described antiapoptotic and cell-cycle retardant effect on somatic cells, Bcl2 may also function to enhance induced hematopoietic cell differentiation of murine ES cells. These findings may have potential relevance for expanding hematopoietic stem/progenitor cell numbers from an ES cell source for stem cell transplantation applications.

Indexed as

AnimalsCell DifferentiationCyclin-Dependent Kinase Inhibitor p27Embryonic Stem CellsG1 PhaseGenes, DominantHematopoietic Stem CellsMiceMutationNIH 3T3 CellsProto-Oncogene ProteinsProto-Oncogene Proteins c-bcl-2Resting Phase, Cell CycleRNA, Small InterferingStem Cell TransplantationUp-RegulationBcl2 protein, mouseCdkn1b protein, mouseCyclin-Dependent Kinase Inhibitor p27Proto-Oncogene ProteinsProto-Oncogene Proteins c-bcl-2RNA, Small Interfering

Identifiers

PMID18023519
PMCPMC2253674
OpenAlexW2046879256

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.